Akèy › Kansè zo
Etid klinik pou Kansè zo ap rekrite nan Etazini
19 etid pou Kansè zo ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07193550Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 11, 2026 · NCT07215611Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Ap rekrite
Laj 15 a 39 · Tout sèks · Mizajou Aug 26, 2026 · NCT07662239Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Ap rekrite
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT07514819Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT03965234Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT06409013U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT07325578Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Ap rekriteFaz 1
Laj 12 a 50 · Tout sèks · Mizajou Jul 15, 2026 · NCT03093909XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT06571734Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT05419518Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Ap rekriteFaz 2
Laj 8 a 30 · Tout sèks · Mizajou May 22, 2026 · NCT05726383Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT06129903Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT07197645Mg OSTEOCRETE Post-Treatment Outcomes
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT06720142Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT03442465Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Ap rekriteEtid obsèvasyon
Laj 15 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05033288An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT02677961Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Oct 15, 2025 · NCT03160274Definitive Radiation for High-Risk Spine Metastases
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2025 · NCT06165419Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.